Vitamin D Supplements Could Significantly Reduce the Risk of a Second Heart Attack
Vitamin D is vital for maintaining overall health, influencing bone strength, supporting the immune system, and assisting muscle and nerve function. Recently, researchers have begun examining how vitamin D can impact heart health. Although previous observational studies have linked low vitamin D levels to poor cardiovascular outcomes, clinical trial results have been inconsistent.
A recent study by researchers at Intermountain Health has provided new insights, specifically focusing on individuals who have already experienced a heart attack. The study monitored participants’ vitamin D blood levels and adjusted doses to maintain optimal levels throughout the trial. The results showed that those receiving targeted vitamin D supplementation had their risk of a repeat heart attack reduced by 50% compared to those who did not receive supplementation.
The study was presented at the American Heart Association Scientific Sessions 2025, but the results have not yet been published in a peer-reviewed journal. Despite this, the research highlights the potential for vitamin D to help protect the heart, especially when tailored to individual needs.
The Importance of Tailored Vitamin D Supplementation
According to the Food and Nutrition Board, adults aged 18 to 70 should consume 600 IU (International Units) of vitamin D daily. People can obtain vitamin D through sun exposure, supplements, or foods like fortified cereals and milk, and fatty fish like salmon and tuna.
Vitamin D deficiency can occur due to factors like limited sunlight exposure, poor diet, or underlying health conditions. A blood test can detect this deficiency, and in some cases, doctors may recommend high doses of vitamin D supplements.
Researchers have been exploring vitamin D’s potential cardiovascular benefits, particularly for those who have experienced a heart attack. The latest study sought to address inconsistent findings in previous trials by adjusting the vitamin D3 dosage based on individual needs rather than administering a standard dose to all participants.
The study, called the TARGET-D trial, involved 630 participants with an average age of 63, most of whom were male. Participants were enrolled within a month of their heart attack. At the start, 87% of participants had low vitamin D levels, with the average level being 27 ng/ml. The target level was set at 40 ng/ml.
Nearly 60% of participants received an initial dose of 5,000 IU of vitamin D, and their levels were regularly monitored and adjusted as needed.
Positive Results for Heart Attack Survivors
During the study, the researchers tracked major cardiovascular events, including death, heart attack, heart failure, and stroke. While there was no significant difference between groups for all cardiovascular events, the group receiving targeted vitamin D3 treatment had half the number of follow-up heart attacks compared to the control group. The follow-up heart attack rate in the vitamin D group was 3.8%, while the control group had a rate of 7.9%.
While the study didn’t show a reduction in all major cardiac outcomes, the targeted vitamin D3 supplementation was shown to significantly reduce the risk of a second heart attack.
Need for Larger Trials
The researchers are planning to conduct a larger clinical trial to confirm these findings. Experts in the field, including cardiologists and researchers, have noted the potential of vitamin D3 to improve heart health by reducing inflammation and lowering blood pressure. While the evidence is still inconclusive, the results of this study could pave the way for future research.
Dr. Cheng-Han Chen, an interventional cardiologist, cautioned that while higher blood levels of vitamin D are often associated with lower heart disease rates, the relationship is likely more of a correlation than causation. However, if larger studies confirm these findings, it could mark a significant shift in how heart disease is managed, particularly in preventing recurrent heart attacks.
Louis Malinow, MD, also acknowledged the significance of this study, noting that previous vitamin D trials failed due to broad, undifferentiated dosing. He suggested that correcting vitamin D deficiency could improve arterial health, reduce blood pressure, and decrease inflammation — all of which play a role in heart disease.
Malinow also pointed out that earlier correction of vitamin D deficiency might yield even stronger benefits, particularly for high-risk individuals who have not yet had a heart event. He suggested that future studies should aim to target a higher vitamin D level for optimal heart health.
Conclusion
While further research is needed to fully confirm the results, this study highlights the potential of tailored vitamin D supplementation to reduce the risk of a second heart attack. It could be a crucial step forward in the management of cardiovascular health, especially for those who have already experienced heart attacks.
